Search by Drug Name or NDC

    NDC 70069-0382-05 HALOPERIDOL DECANOATE 50 mg/mL Details

    HALOPERIDOL DECANOATE 50 mg/mL

    HALOPERIDOL DECANOATE is a INTRAMUSCULAR INJECTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Somerset Therapeutics, LLC. The primary component is HALOPERIDOL DECANOATE.

    Product Information

    NDC 70069-0382
    Product ID 70069-382_f6d888a0-65a7-4073-8671-b00b4bfaff4c
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name HALOPERIDOL DECANOATE
    Proprietary Name Suffix n/a
    Non-Proprietary Name HALOPERIDOL DECANOATE
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION
    Route INTRAMUSCULAR
    Active Ingredient Strength 50
    Active Ingredient Units mg/mL
    Substance Name HALOPERIDOL DECANOATE
    Labeler Name Somerset Therapeutics, LLC
    Pharmaceutical Class Typical Antipsychotic [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA209101
    Listing Certified Through 2024-12-31

    Package

    NDC 70069-0382-05 (70069038205)

    NDC Package Code 70069-382-05
    Billing NDC 70069038205
    Package 5 VIAL, MULTI-DOSE in 1 CARTON (70069-382-05) / 5 mL in 1 VIAL, MULTI-DOSE
    Marketing Start Date 2020-04-04
    NDC Exclude Flag N
    Pricing Information N/A